Voorbeelden van het gebruik van Clinical development programme in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
The Xultophy clinical development programme included approximately 1,900 patients treated with Xultophy.
The adverse drug reactions were determined based on data from the apremilast clinical development programme.
The Brimica Genuair clinical development programme was conducted in patients with moderate or severe COPD.
Sudden death attributable to underlying cardiovascular disease observed during the clinical development programme.
In the clinical development programme, 1,085 patients with a baseline eGFR 30 mL/min/1.73 m2 to<
The safety profile presented in Table 1 is based on the gefitinib clinical development programme and postmarketed experience.
In the COPD clinical development programme a total of 6,237 subjects were included in an integrated assessment of adverse reactions.
including one fatal, have been reported across the clinical development programme of olaratumab see section 4.4.
The Oslif Breezhaler Phase III clinical development programme involved patients with a clinical diagnosis of moderate to severe COPD.
is in clinical use since the 1960ies, thereby explaining the lack of a clinical development programme.
During the clinical development programme the occurrence of cases of melanoma prompted the consideration of a possible association with rasagiline.
including Stevens-Johnson syndrome, were reported in less than 1% of patients included in the clinical development programme.
Microdosing will allow companies to focus their clinical development programmes on those candidates with the most suitable kinetic profile in humans.
The clinical development programme included one 12-week,
Patients taking methadone for treatment of opioid addiction were not included in the clinical development programme and use of naloxegol in these patients should be approached with caution.
to support the clinical development programme.
optimise not only clinical development programmes for products but also the management
The COPD clinical development programme included a 12-week(HZC113107), two 6-month(HZC112206, HZC112207) and two one-year(HZC102970,
These were reported during the Phase 3 clinical development programme, which included a total of 1,030 chronic angina patients treated with Ranexa.
The TOBI Podhaler Phase III clinical development programme consisted of two studies